Assembly Biosciences Analyst Ratings
Assembly Biosciences Analyst Ratings
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
Assembly Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Viking Therapeutics (VKTX) and Assembly Biosciences (ASMB)
H.C. Wainwright Sticks to Their Hold Rating for Assembly Biosciences (ASMB)
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and Assembly Biosciences (ASMB)
H.C. Wainwright Keeps Their Hold Rating on Assembly Biosciences (ASMB)
Assembly Biosciences (ASMB) Receives a Buy From Mizuho Securities
Analysts Have Conflicting Sentiments on These Healthcare Companies: Clearside Biomedical (CLSD), Assembly Biosciences (ASMB) and ScPharmaceuticals (SCPH)
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Selecta Biosciences (SELB) and Assembly Biosciences (ASMB)
HC Wainwright Adjusts Price Target on Assembly Biosciences to $1.50 From $2.50, Keeps Neutral Rating
Assembly Biosciences (ASMB) Gets a Hold From H.C. Wainwright
Assembly Biosciences (ASMB) Gets a Buy From Mizuho Securities
Assembly Biosciences (ASMB) Gets a Buy From Mizuho Securities
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB) and Evolus (EOLS)
H.C. Wainwright Keeps Their Hold Rating on Assembly Biosciences (ASMB)
Assembly Biosciences (ASMB) Receives a Buy From Mizuho Securities
Assembly Biosciences Analyst Ratings